Preferred Label : glucagon;
MeSH definition : A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor
of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS
and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism,
and several other biochemical and physiological processes. (From Gilman et al., Goodman
and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511);
MeSH synonym : proglucagon (33-61); hg-factor; glukagon; hg factor; hyperglycemic-glycogenolytic factor; hyperglycemic glycogenolytic factor; glucagon (1-29);
Registry Number MeSH : 9007-92-5;
MeSH annotation : do not confuse with GLUCAGON-LIKE PEPTIDES secreted by the intestine;
Wikipedia link : https://en.wikipedia.org/wiki/Glucagon;
Codes EINECS : 232-708-2;
Is substance : O;
Origin ID : D005934;
UMLS CUI : C0017687;
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Currated CISMeF NLP mapping
- glucagon [Artificial nutrition thesaurus concept]
Indexing information
Manual BTNT mappings - CISMeF
Ne pas confondre avec
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
- HM15136 [MeSH Supplementary Concept]
- S 23521 [MeSH Supplementary Concept]
- ZP2495 [MeSH Supplementary Concept]
See also
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor
of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS
and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism,
and several other biochemical and physiological processes. (From Gilman et al., Goodman
and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511)
https://ansm.sante.fr/tableau-marr/glucagon
2024
false
false
false
France
French
guidelines for drug use
risk management
glucagon
glucagon
administration, intranasal
patient education handout
---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/glucagen-1-mg-ml-poudre-et-solvant-pour-solution-injectable-glucagon-chlorhydrate-de
2022
false
false
false
France
French
drug recalls
drug information
glucagon
injections
glucagon
---
https://www.ema.europa.eu/en/medicines/human/EPAR/ogluo
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
glucagon
glucagon
glucagon
child
adolescent
adult
aged
hypoglycemia
diabetes mellitus
Hypoglycemia due to diabetes mellitus (disorder)
hormones
hormones
injections, subcutaneous
drug interactions
pregnancy
breast feeding
---
https://www.has-sante.fr/jcms/p_3260463/fr/baqsimi
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
glucagon
administration, intranasal
glucagon
adult
adolescent
child
hypoglycemia
Insulin hypoglycemia
hormones
evaluation of the transparency committee
---
https://www.ema.europa.eu/en/medicines/human/EPAR/baqsimi
2020
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
glucagon
drug approval
europe
treatment outcome
hypoglycemia
adult
adolescent
child
administration, intranasal
glucagon
drug interactions
pregnancy
breast feeding
Hypoglycemia due to diabetes mellitus (disorder)
glucagon
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-07/glucagen_-_ct-7342.pdf
http://www.has-sante.fr/portail/jcms/c_969966/glucagen-glucagen-kit
2010
France
French
diagnostic uses of chemicals
glucagon
hormones
glucagon
insurance, health, reimbursement
gastrointestinal agents
glucagon
hypoglycemia
insulin
hypoglycemia
gastrointestinal diseases
injections
evaluation of the transparency committee
---